Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuula Pirttilä

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|April 7, 2004
[Pain and cognition]Tuula Pirttilä, Taina Nybo
Duodecim; Laaketieteellinen Aikakauskirja|April 1, 2005
[Are Alzheimer's drugs effective?]Soininen Hilkka, Tuula Pirttilä
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patientsJanne Martikainen, Hannu Valtonen, Tuula Pirttilä
Acta Neuropathologica|February 26, 2008
Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevanceLaura Parkkinen, Tuula Pirttilä, Irina Alafuzoff
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 31, 2005
Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subjectLaura Parkkinen, Tuula Pirttilä, Markku Tervahauta, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2008
CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophySanna-Kaisa Herukka, Corina Pennanen, Hilkka Soininen, et al.
Neurology|April 13, 2005
CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairmentSanna-Kaisa Herukka, Merja Hallikainen, Hilkka Soininen, et al.
Biochemical and Biophysical Research Communications|November 7, 2002
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylationPetri Kerokoski, Tiina Suuronen, Antero Salminen, et al.
Journal of Neurochemistry|January 7, 2010
An update on clinical proteomics in Alzheimer's researchMinna A Korolainen, Tuula A Nyman, Tero Aittokallio, et al.
Brain Research. Molecular Brain Research|October 24, 2002
Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35Petri Kerokoski, Tiina Suuronen, Antero Salminen, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Duodecim; Laaketieteellinen Aikakauskirja|April 7, 2004
[Pain and cognition]Tuula Pirttilä, Taina Nybo
Duodecim; Laaketieteellinen Aikakauskirja|April 1, 2005
[Are Alzheimer's drugs effective?]Soininen Hilkka, Tuula Pirttilä
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patientsJanne Martikainen, Hannu Valtonen, Tuula Pirttilä
Acta Neuropathologica|February 26, 2008
Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevanceLaura Parkkinen, Tuula Pirttilä, Irina Alafuzoff
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 31, 2005
Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subjectLaura Parkkinen, Tuula Pirttilä, Markku Tervahauta, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2008
CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophySanna-Kaisa Herukka, Corina Pennanen, Hilkka Soininen, et al.
Neurology|April 13, 2005
CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairmentSanna-Kaisa Herukka, Merja Hallikainen, Hilkka Soininen, et al.
Biochemical and Biophysical Research Communications|November 7, 2002
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylationPetri Kerokoski, Tiina Suuronen, Antero Salminen, et al.
Journal of Neurochemistry|January 7, 2010
An update on clinical proteomics in Alzheimer's researchMinna A Korolainen, Tuula A Nyman, Tero Aittokallio, et al.
Brain Research. Molecular Brain Research|October 24, 2002
Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35Petri Kerokoski, Tiina Suuronen, Antero Salminen, et al.
Pageof 6